Neuroscience
Neuroscience research groups within SBMS broadly engage with the full translational pathway of biomedical research in the brain and nervous system, from basic discovery at the bench to applied research spanning from AI-informed drug discovery to first-in-human clinical trials. This landscape offers extensive training opportunities through more than 15 collaborating research themes (aligned to the Neuroscience Hons program and HDR pathway), spanning from single-molecule science, to molecular, cellular and systems physiology and pharmacology, behavioural, electrophysiological and advanced imaging research modalities. SBMS Neuroscience is supported by the core capabilities of the ‘Translational Neuroscience Facility’ with a focus on physiological readout, including dedicated surgical and behavioural suites, viral vector and gene electrotransfer platforms and advanced multi-photon physiological imaging. This is complemented by facilitated access to MWAC facilities, including the KGLM light microscopy facility, BRIL instrumentation for intravital MRI / PET-CT animal imaging and spatially resolved brain multi-omics platforms for next-generation in situ cell-type mapping. SBMS neuroscience research and training is strongly supported by competitive external funding to address a wide range of neurological disorders and fundamental brain sciences. Themes within SBMS Neuroscience include DNA / RNA -based therapeutics directed at nerve regeneration with age and trauma, focal epilepsy, vision disorders, white-matter diseases (leukodystrophies). Translationally-focused research around sensorimotor disabilities include: neuropathic pain, hearing loss, touch sensation (proprioception) and peripheral neuropathies, control of breathing (sleep apnoea), blood pressure and stress responses, learning, memory and addiction brain circuit plasticity, neural cytoskeletal regulation and brain cell interaction, stroke and traumatic brain injury, and Parkinson’s Disease.